ASX:AV1 Adveritas (AV1) Stock Price, News & Analysis → Banking Apocalypse Ahead: Secure Your Savings Today! (From Weiss Ratings) (Ad) Free AV1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume457,475 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Adveritas alerts: Email Address Ad Behind the MarketsRevealed: The Unknown Biotech Powering AI in HealthcareThe CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.To discover the name and ticker of this hidden gem click here>>>> About Adveritas Stock (ASX:AV1)Adveritas Limited provides funnel measurement, verification, and fraud prevention solutions for digital advertising in Australia and internationally. It develops TrafficGuard, a fraud mitigation software as a service that detects, mitigates, and reports on digital ad fraud before it hits advertising budgets; and nxus, a proprietary ad mediation platform to track and attribute channel activity to identify profitable advertising channels. The company was formerly known as Tech Mpire Limited and changed its name to Adveritas Limited in December 2018. The company was incorporated in 2012 and is based in Bentley, Australia.Read More Ad Behind the MarketsRevealed: The Unknown Biotech Powering AI in HealthcareThe CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.To discover the name and ticker of this hidden gem click here>>>> AV1 Stock News HeadlinesMay 31, 2023 | benzinga.comTech Stock Capital Raises On ASX: To Invest Or Not To Invest?February 1, 2023 | msn.comAdveritas placement snapped up like hot cakes at 13% premiumNovember 30, 2022 | msn.comTop 10 at 10: Which battery metals play has a new key claim in Canada lithium country?November 24, 2022 | msn.comTop 10 at 10: Here are Friday’s best performing ASX stocks at the openNovember 24, 2022 | afr.comNASDAQ’s Integral Ad Science calls for Aussie microcap AdveritasSeptember 2, 2022 | ca.finance.yahoo.comHealth Check: How Prudently Does Adveritas (ASX:AV1) Use Debt?March 11, 2022 | uk.news.yahoo.comPlans revealed for five new 'accommodation pods' at Swindon hotelMarch 9, 2022 | ca.finance.yahoo.comWe're Keeping An Eye On Vox Royalty's (CVE:VOX) Cash Burn RateMarch 8, 2022 | finance.yahoo.comHere's Why We're Watching Adveritas' (ASX:AV1) Cash Burn SituationAugust 30, 2021 | msn.comFraud preventer Adveritas ready for big new markets in FY22 after strong growthAugust 27, 2021 | ca.finance.yahoo.comInstagram is testing ‘interest search’ to make results more intuitiveAugust 27, 2021 | yahoo.comBlake Lively and Ryan Reynolds Donate $10K for Haiti Earthquake ReliefAugust 27, 2021 | ca.finance.yahoo.comMexico: President foe who fled allegedly got $500,000 bribeAugust 27, 2021 | uk.finance.yahoo.comWhy Mastercard is stripping the stripe from its credit cardsAugust 25, 2021 | finance.yahoo.comAdveritas Limited (ASX:AV1) insiders placed bullish bets worth AU$1.3m in the last 12 monthsAugust 24, 2021 | msn.comAdveritas signs up the fast growing sectors of online betting and Indian ecommerce, boosting revenue furtherAugust 1, 2021 | msn.comAdveritas’ global customer base has grown to the UK, Asia and South America – and with it, revenuesJuly 30, 2021 | msn.comAdveritas books major revenue upgrade as it prepares to go live on Google Cloud in FY22See More Headlines Receive AV1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adveritas and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Software - Infrastructure Sub-IndustryN/A Current SymbolASX:AV1 CUSIPN/A CIKN/A Webwww.adveritas.com.au Phone61 8 9473 2500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,280,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-497.49% Return on Assets-132.35% Debt Debt-to-Equity Ratio150.66 Current Ratio0.92 Quick Ratio2.68 Sales & Book Value Annual Sales$3.23 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.60 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares788,410,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.68 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mathew RattyFounder, CEO, MD & DirectorMs. Fiona MuirChief Financial OfficerMr. Matt SuttonChief Operating OfficerMr. Chadwick KinlayChief Marketing OfficerMr. Elie ShuggiChief Product OfficerKey CompetitorsAdslotASX:ADSAdyenOTCMKTS:ADYYFAEyeNASDAQ:LIDRWAfterpayASX:APTAfterpayOTCMKTS:AFTPFView All CompetitorsInsidersMark McConnellSold 5,000,000 sharesTotal: $250,000.00 ($0.05/share)Joshua LowcockBought 163,000 shares on 8/9/2023Total: $7,498.00 ($0.05/share)Mark McConnellBought 500,000 shares on 8/4/2023Total: $23,500.00 ($0.05/share)Mark McConnellSold 10,416,666 sharesTotal: $499,999.97 ($0.05/share)Mark McConnellSold 10,416,667 sharesTotal: $500,000.02 ($0.05/share) This page (ASX:AV1) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adveritas Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.